Front > MARKET


Dror Ben-Asher Photo: Arik Soltan RedHill Biopharma raises $20m on Nasdaq

The Israeli company will use the funds for the commercial launch of H.pylori drug TALICIA and two phase III clinical trials.

Reshet-Channel 10 merger  image: Shutterstock Blavatnik, Recanati to control merged Channel 10 - Reshet

Together with Nadav Topolski, Blavatnik and Recanati's company will hold 68% of the merged channel shares.

Yoav Turgeman Photo: IAI IAI Elta wins $60m Asian fighter jet radar, EW deals

The products to be delivered are based on the latest technologies providing the customer's air force fighter jets with high performing radar sensing.

Store replacing Children's Place Photo: Shany Moses Fashion stores abandoning Gindi TLV mall

Three of Israel's largest fashion groups have vacated stores in the 'fashion' mall in Tel Aviv.

Vitania Towers Photo: Yashar Architects 3 towers approved for Tel Aviv's La Guardia Interchange

Vitania will build three high-rise towers including offices, hotels, commerce, and residences.

Mergers and acquisitions Photo: To Go China's TAL buys Israeli education games co Codemonkey

The Tel Aviv based company, which teaches children programing skills through games, has been acquired for $20 million.

Israel-Lebanese border Photo: Reuters Israel developing new laser missile defense system

As the missile threat grows in the north, the Ministry of Defense is speeding up development of the system, which a source says is on the verge of being ready.

Cellcom Cellcom, Bezeq raising debt

Bezeq has completed a NIS 578 million expansion of its Series 9 bonds, and Cellcom is set to raise NIS 300 million.

medical cannabis Cannbit to sell medical cannabis to Tikun Olam

Tikun Olam will be short of cannabis until its Kfar Yehoshua farms is approved.

Daniel Birnbaum Photo: Eyal Izhar PepsiCo completes acquisition of SodaStream

PepsiCo has acquired all outstanding shares of the Israeli carbonated drinks company for $144 per share, at a company valuation of $3.2 billion.

Cup 'O' Joe Photo: Eyal Izhar Ilan's in advanced talks to buy Cup 'O' Joe cafe chain

With 40 cafes and 200 points-of-sale, Cup 'O' Joe is controlled by Delek.

Avi Brenmiller Photo; Company Brenmiller to install storage tech at Enel power plant

Brenmiller Energy CEO Avi Brenmiller: This  opportunity is an important breakthrough for the company

Yuval Cohen Fortissimo sells remaining stake in Kornit Digital

Private equity firm Fortissimo Capital invested $19 million in Kornit Digital in 2011, and over the years has sold its shares for a total of about $300 million.

US real estate  image: Shutterstock TASE-listed US real estate co bonds reach junk levels

Problems at Brookland, All Year Holdings and Delshah Capital, among others, have affected investor sentiment towards the entire sector.

Moshe Kahlon  photo: Eyal Izhar Mortgage arrears rise steeply

The trend of increasing mortgage arrears in Israel that started last year has accelerated considerably in the past few months.

Raviv Zoller Photo: Shlomi Yosef Israel Chemicals sues IBM for $300m

Israel Chemicals alleges that a huge, group-wide IT project failed because of IBM's incompetence. IBM: The case has no merit.

Bezhalel Machlis Photo: Tamar Matsafi Elbit awarded $112m airborne intelligence deal

The contract for an Asia-Pacific country will be performed over six years.

Leviathan gas field Photo: Noble Energy IEC seeks Tamar, Leviathan bids for NIS 2b gas deal

Israel Electric Corp. is hoping to cut the price of gas by generating competition between the two partnerships.

Rimonim Central Park Hotel, Eilat  photo: PR Dan Hotels eyes Rimonim hotel chain

Negotiations on buying Israel Land Development Hotels Ltd., which owns the Rimonim chain, are at a price of NIS 140 million.

Robert Antokol  photo: Efi Sameach Playtika buys German games co Wooga

Market sources put the acquisition price for Berlin-based casual games company Wooga at over $100 million.

Mobileye campus Photo: Moshe Tsur Afcon to build Mobileye's Jerusalem campus

The 135,000-square meter campus will have a 40-floor building and eight eight-floor buildings.

Benjamin Netanyahu, Shaul Elovitch: Tamar Matsafi Police recommend indicting Netanyahu, Elovitch for bribery

Elovitch is suspected of dictating favorable coverage on the Walla! website, which he controlled, in exchange for regulatory favors for Bezeq, which he also controlled.

Tnuva  picture: Tamar Mitzpi Tnuva declares NIS 200m dividend

The dividend, to be paid to China's Bright Food and the kibuutzim, comes after Tnuva hiked prices of non-controlled milk products.

El Al   photo: Sivan Farag Pact with pilots puts El Al at risk

As its market share declines, will efficiency gains outweigh the cost of El Al's generosity to its pilots.

Elisabeth Kogan Photo: PR Teva's loss is Israeli pharma industry's gain

Disinvestment by Teva from Israeli companies and thousands of employees laid off have had advantages for Israel's pharma industry, including successful startups.

Medical cannabis Photo: Shutterstock The state of medical cannabis

"Globes" surveys Israel's medical cannabis sector, in which  more than 100 companies are already operating.

Maurice Ferre Photo: PR Insightec CEO confident of $30-50 billion exit

Maurice Ferré says that the Israeli company's medical device technology is a game changer in incisionless surgery.

Kare Schultz Photo: PR Teva sacrifices long-term growth for stability

One year into the job, Teva CEO Kare Schultz has halted the plunge in the company's share price and restored investor confidence, but what of the future?

IMI Systems rocket Photo: PR Elbit to acquire IMI Systems next week for NIS 1.9b

The merger with IMI will give Elbit Systems a foothold in precision rockets, cruise missiles, and active protection for tanks and AFVs.

Nicole Neghaiwi  photo: Ronen Mahlev "Impact investment must continue to develop"

UBS Impact Investment Strategist Nicole Neghaiwi talks to "Globes" about how investment decisions can, and must, help make the world a better place.

Aharon Lutzky "Next for Tikun Olam: A cannabis pharmacy"

CEO Aharon Lutzky talks about the $400 million medical cannabis company's special business model, and its ambitions.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018